Captopril given intracerebroventricularly, subcutaneously or by gavage inhibits angiotensin-converting enzyme activity in the rat brain
- 1 December 1980
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 68 (4) , 443-449
- https://doi.org/10.1016/0014-2999(80)90419-7
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Effects of captopril (SQ 14, 225) on the renin-angiotensin-aldosterone system in normal ratsEuropean Journal of Pharmacology, 1980
- Prevention of the development of spontaneous hypertension in rats by captopril (SQ 14,225)European Journal of Pharmacology, 1979
- Effects of an Orally Active Converting-Enzyme Inhibitor, SQ 14225, on Pressor Responses to Angiotensin Administered into the Brain Ventricles of Spontaneously Hypertensive RatsClinical Science, 1979
- Design of new antihypertensive drugs: Potent and specific inhibitors of angiotensin-converting enzymeProgress in Cardiovascular Diseases, 1978
- The renin system in high blood pressure, from disbelief to reality: Converting-enzyme blockade for analysis and treatmentProgress in Cardiovascular Diseases, 1978
- Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patientsProgress in Cardiovascular Diseases, 1978
- Angiotensin in the BrainNeuroendocrinology, 1978
- The effect on drinking of peptide precursors and of shorter chain peptide fragments of angiotensin II injected into the rat's diencephalonThe Journal of Physiology, 1971
- Fate of Angiotensin I in the CirculationNature, 1968
- Extension of Multiple Range Tests to Group Means with Unequal Numbers of ReplicationsPublished by JSTOR ,1956